OTC : MAHLY

MediPal Holdings Corporation

$17.99 USD

$0 (0.0%)

Volume
100
Average Volume
74
Market Capitalization
$3.68B
P/E Ratio
13.81
Dividend Yield
2.31%
Price Target
Year High
$20.35
Year Low
$15.37
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.28
Company Overview

OTC

Shuichi Watanabe

Medical - Distribution

Healthcare

MAHLY

13024

JP

USD

https://www.medipal.co.jp

81 3 3517 5800

58502T107

N/A

Liquidity Metrics

0.00

1.28

1.11

0.27

0.00

Sales & Valuation

$4.05T

0.15

0.89

0.00

0.00

Profitability

$218.9

$45.1B

1.11%

2.14%

6.72%

2.21%

P/E Metrics

13.81

1.97

1.97

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

2.99

5/9

$304.3B

$1.93T

$1.13T

$73.01B

Key Metrics (TTM)

$295.14B

0.08

2.68

1.28

6.72%

4.04%

7.33%

0.00%

$3888.02

3 days

Company Executives
Name Title
Kuniaki Imagawa MD, Deputy Head of Pharmaceutical Business & Director
Shinjiro Watanabe MD, GM of Information Systems Management Division & Director
Yuji Sakon MD, GM of Administration Division & Director
Shuichi Watanabe Chief Compliance Officer, Chief Executive Officer, President & Representative Director
Toshihide Yoda Senior MD of Investor Relations, GM of Business Development Department & Director
Yasuhiro Choufuku Executive Vice President & Representative Director
Toshiyuki Ikeuchi Executive Officer & Head of Corporate Communications Department, Corporate Planning Division
Poll Results

No votes yet today — be the first to share your view!

About MediPal Holdings Corporation (OTC:MAHLY) Stock

Medipal Holdings Corporation, a Tokyo-based Japanese company founded in 1898, primarily operates as a wholesaler of prescription pharmaceuticals throughout Japan. Beyond its core drug distribution, the company also sources and supplies a comprehensive range of healthcare-related products, including medical equipment, materials, and clinical diagnostic reagents, used from the earliest pre-symptomatic stages through treatment. Its services extend to offering post-marketing surveillance (PMS) to pharmaceutical manufacturers and investing in the development of orphan drugs. Medipal's extensive wholesale activities also encompass a diverse array of other goods, such as cosmetics, daily necessities, over-the-counter medications, and animal health products for companion animals. Furthermore, it p ... rovides raw materials for food processing in agriculture, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. In addition to its product distribution, Medipal delivers a suite of specialized services: conducting contract-based epidemiological and clinical studies, developing computerized medical supply and master product databases for healthcare facilities, and offering solutions for health insurance claims review, medical coding, outsourcing, and remote educational programs. Its operations further include managing life and non-life insurance agencies, providing cleaning services, overseeing distribution center logistics, offering commissioned delivery and staffing solutions, and developing and managing services for Class A health dispensing pharmacies. Medipal serves a broad client base, including hospitals, clinics, dispensing pharmacies, various retail outlets like drugstores, home centers, convenience stores, supermarkets, and discount stores, as well as animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was previously known as Mediceo Paltac Holdings Co., Ltd. before adopting its current name in October 2009.

Frequently Asked Questions

What is the current MediPal Holdings Corporation (MAHLY) stock price?

MediPal Holdings Corporation(OTC:MAHLY) stock price is $17.99 in the last trading session. During the trading session, MAHLY stock reached the peak price of $20.35 while $15.37 was the lowest point it dropped to. The percentage change in MAHLY stock occurred in the recent session was 0.0% while the dollar amount for the price change in MAHLY stock was $0.

MAHLY's industry and sector of operation?

The OTC listed MAHLY is part of Medical - Distribution industry that operates in the broader Healthcare sector.

Who are the executives of MAHLY?

Kuniaki Imagawa | MD, Deputy Head of Pharmaceutical Business & Director
Shinjiro Watanabe | MD, GM of Information Systems Management Division & Director
Yuji Sakon | MD, GM of Administration Division & Director
Shuichi Watanabe | Chief Compliance Officer, Chief Executive Officer, President & Representative Director
Toshihide Yoda | Senior MD of Investor Relations, GM of Business Development Department & Director

How many employees does MAHLY have?

Number of MAHLY employees currently stands at 13024. MAHLY operates from 2-7-15, Yaesu, Tokyo, TY 104-8461, JP.

Link for MAHLY official website?

Official Website of MAHLY is: https://www.medipal.co.jp

How do I contact MAHLY?

MAHLY could be contacted at phone #81 3 3517 5800 and can also be accessed through its website. MAHLY operates from 2-7-15, Yaesu, Tokyo, TY 104-8461, JP.

How many shares of MAHLY are traded daily?

The average number of MAHLY shares traded daily for last 3 months was 74.

What is the market cap of MAHLY currently?

The market value of MAHLY currently stands at $3.68B with its latest stock price at $17.99